Journal of Applied Genetics,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 8, 2025
Abstract
Cannabidiol
(CBD)
is
a
compound
found
in
Cannabis
sativa
that
known
for
its
neuroprotective,
anti-inflammatory,
analgesic,
and
anxiolytic
properties.
These
properties
make
it
promising
treatment
various
neurological
conditions.
This
study
aimed
to
examine
the
effects
of
CBD
on
hypothalamic
neurons
at
transcriptome
level
using
adult-derived
mHypoA-2/12
mouse
cell
line.
The
cells
were
exposed
four
different
concentrations
(ranging
from
0.325
3
µM)
6
24
h.
Apart
analysis,
apoptosis
(caspase
3/7
activity)
viability
(MTT)
assays
performed.
obtained
results
showed
enhanced
viability,
especially
after
h
lower
or
intermediate
concentrations,
reduced
apoptosis,
with
significant
highest
concentration.
caused
moderate
profile
changes
(13
69
genes
per
treatment),
more
affected
higher
shorter
exposure
times,
indicating
stronger
initial
cellular
response.
Further
analysis
revealed
affects
several
biological
processes,
including:
intrinsic
suppression
via
p53
modulation,
impacting
like
Bbc3
,
Mdm2
Cdkn1a
Smad3
.
Additionally,
influenced
involved
extracellular
matrix
organization,
including
metalloproteinases
(
Mmp-3
Mmp-13
)
their
inhibitors
Timp1
),
as
well
collagen
components
Col11a1
mitochondrial
respiratory
chain
complexes
mt-Nd5
mt-Nd4
).
Genes
related
serotonin
dopamine
biosynthesis,
Aldh2
also
impacted,
linking
CBD’s
potential
benefits
managing
alcohol
use
disorders.
findings
suggest
hypothalamus
target
CBD,
warranting
further
investigation.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Май 11, 2023
Abstract
Synthetic
biology
aims
to
design
or
assemble
existing
bioparts
bio-components
for
useful
bioproperties.
During
the
past
decades,
progresses
have
been
made
build
delicate
biocircuits,
standardized
biological
building
blocks
and
develop
various
genomic/metabolic
engineering
tools
approaches.
Medical
pharmaceutical
demands
also
pushed
development
of
synthetic
biology,
including
integration
heterologous
pathways
into
designer
cells
efficiently
produce
medical
agents,
enhanced
yields
natural
products
in
cell
growth
media
equal
higher
than
that
extracts
from
plants
fungi,
constructions
novel
genetic
circuits
tumor
targeting,
controllable
releases
therapeutic
agents
response
specific
biomarkers
fight
diseases
such
as
diabetes
cancers.
Besides,
new
strategies
are
developed
treat
complex
immune
diseases,
infectious
metabolic
disorders
hard
cure
via
traditional
In
general,
brings
capabilities
researches.
This
review
summarizes
timeline
developments,
present
microbial
productions
pharmaceutics,
engineered
equipped
with
DNA
diagnosis
therapies,
live
auto-assemblied
biomaterials
treatments,
cell-free
fields,
approaches
potentials
biomedical
applications.
Molecules,
Год журнала:
2023,
Номер
28(16), С. 5980 - 5980
Опубликована: Авг. 9, 2023
Cannabidiol
(CBD)
is
the
primary
non-psychoactive
chemical
from
Cannabis
Sativa,
a
plant
used
for
centuries
both
recreational
and
medicinal
purposes.
CBD
lacks
psychotropic
effects
of
Δ9-tetrahydrocannabinol
(Δ9-THC)
has
shown
great
therapeutic
potential.
exerts
wide
spectrum
at
molecular,
cellular,
organ
level,
affecting
inflammation,
oxidative
damage,
cell
survival,
pain,
vasodilation,
excitability,
among
others,
modifying
many
physiological
pathophysiological
processes.
There
evidence
that
may
be
effective
in
treating
several
human
disorders,
like
anxiety,
chronic
psychiatric
pathologies,
cardiovascular
diseases,
even
cancer.
Multiple
cellular
pre-clinical
studies
using
animal
models
disease
trials
have
an
overall
safe
profile.
In
this
review
article,
we
summarize
pharmacokinetics
data,
putative
mechanisms
action
CBD,
reported
to
give
comprehensive
list
findings
major
attributed
compound.
Trends in Pharmacological Sciences,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Cannabidiol
(CBD),
the
primary
non-intoxicating
compound
in
cannabis,
is
currently
approved
for
treating
rare,
treatment-resistant
seizures.
Recent
preclinical
research
suggests
that
CBD's
multifaceted
mechanisms
of
action
brain,
which
involve
multiple
molecular
targets,
underlie
its
neuroprotective,
anti-inflammatory,
anxiolytic,
and
antipsychotic
effects.
Clinical
trials
are
also
exploring
therapeutic
potential
beyond
current
uses.
This
review
focuses
on
polypharmacological
profile
discusses
latest
clinical
findings
regarding
efficacy
neuropsychiatric
disorders.
Existing
evidence
ability
to
modulate
signaling
pathways
may
benefit
disorders,
we
propose
further
areas
clarify
mechanisms,
address
data
gaps,
refine
indications.
Redox Biology,
Год журнала:
2022,
Номер
57, С. 102489 - 102489
Опубликована: Сен. 29, 2022
Cannabidiol
(CBD),
the
major
non-psychoactive
phytocannabinoid
of
Cannabis
sativa
L.,
is
one
most
studied
compounds
in
pharmacotherapeutic
approaches
to
treat
oxidative
stress-related
diseases
such
as
cardiovascular,
metabolic,
neurodegenerative,
and
neoplastic
diseases.
The
literature
data
date
indicate
possibility
both
antioxidant
pro-oxidative
effects
CBD.
Thus,
mechanism
action
this
natural
compound
regulation
nuclear
factor
2
associated
with
erythroid
(Nrf2),
which
plays
role
main
cytoprotective
regulator
redox
balance
inflammation
under
stress
conditions,
seems
be
particularly
important.
Moreover,
Nrf2
strongly
correlated
cellular
profile
malignancy,
turn
critical
determining
response
induced
by
CBD
pathophysiological
conditions.
This
paper
summarizes
CBD-mediated
pathways
system
altering
expression
modification
proteins
directly
involved
transcriptional
activity
relationship
between
kappa
B
(NF-κB)
another
redox-sensitive
transcription
factor.
Antioxidants,
Год журнала:
2023,
Номер
12(2), С. 485 - 485
Опубликована: Фев. 14, 2023
The
literature
provides
scientific
evidence
for
the
beneficial
effects
of
cannabidiol
(CBD),
and
these
extend
beyond
epilepsy
treatment
(e.g.,
Lennox–Gastaut
Dravet
syndromes),
notably
influence
on
oxidative
status,
neurodegeneration,
cellular
protection,
cognitive
function,
physical
performance.
However,
products
containing
CBD
are
not
allowed
to
be
marketed
everywhere
in
world,
which
may
ultimately
have
a
negative
effect
health
as
result
uncontrolled
market.
After
isolation
follows
discovery
CB1
CB2
receptors
main
enzymatic
components
(diacylglycerol
lipase
(DAG
lipase),
monoacyl
glycerol
(MAGL),
fatty
acid
amino
hydrolase
(FAAH)).
At
same
time,
antioxidant
potential
is
due
only
molecular
structure
but
also
fact
that
this
compound
increases
expression
endogenous
systems,
superoxide
dismutase
(SOD),
glutathione
peroxidase
(GPx),
through
nuclear
complex
erythroid
2-related
factor
(Nrf2)/Keep1.
Regarding
role
control
inflammation,
function
exercised
by
inhibiting
(nuclear
kappa
B)
NF-κB,
genes
encode
molecules
with
pro-inflammatory
(cytokines
metalloproteinases).
other
performance
should
excluded.
In
conclusion,
market
needs
regulated
more
thoroughly,
given
previously
listed
properties,
mention
safety
profile
very
good
one.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(3), С. 2513 - 2513
Опубликована: Янв. 28, 2023
Cannabis
sativa-derived
compounds,
such
as
delta-9-tetrahydrocannabinol
(THC)
and
cannabidiol
(CBD),
components
of
the
endocannabinoids
system,
N-arachidonoylethanolamide
(anandamide,
AEA)
2-arachidonoylglycerol
(2-AG),
are
extensively
studied
to
investigate
their
numerous
biological
effects,
including
powerful
antioxidant
effects.
Indeed,
a
series
recent
studies
have
indicated
that
many
disorders
characterized
by
alterations
in
intracellular
which
lead
macromolecule
damage.
These
pathological
conditions
an
unbalanced,
most
often
increased,
reactive
oxygen
species
(ROS)
production.
For
this
study,
it
was
interest
recapitulate
properties
these
natural
for
part
CBD
THC,
on
production
ROS
modulation
redox
state,
with
emphasis
use
various
reduction
can
be
clinically
useful,
neurodegenerative
disorders,
inflammatory
conditions,
autoimmunity,
cancers.
The
further
development
ROS-based
fundamental
research
focused
cannabis
compounds
could
beneficial
future
clinical
applications.
Antibiotics,
Год журнала:
2025,
Номер
14(2), С. 136 - 136
Опубликована: Фев. 1, 2025
Background:
Gardnerella
vaginalis
is
a
natural
inhabitant
of
the
vagina,
but
when
an
imbalance
occurs
in
vaginal
microbiota,
this
bacterium
can
cause
vaginosis,
condition
that
must
be
treated
symptomatic
and
prior
to
gynecological
intervention.
Cannabidiol
(CBD)
anti-inflammatory
compound
also
has
antibacterial
activities
against
several
Gram-positive
certain
Gram-negative
bacteria.
Objectives:
Since
G.
opportunistic
pathogenic
Gram-variable
bacterium,
we
investigated
its
response
CBD.
Methods:
The
activity
CBD
was
studied
by
broth
dilution
assay,
changes
intracellular
ATP
levels,
ability
bacteria
recover
on
chocolate
agar
plates.
antibiofilm
MTT
metabolic
crystal
violet
staining,
HR-SEM.
Flow
cytometric
analyses
were
performed
measure
membrane
potential,
perforation,
activity.
Reactive
oxygen
species
(ROS)
production
analyzed
using
nitro
blue
tetrazolium
(NBT)
reagent.
Gene
expression
determined
semi-quantitative
real-time
PCR,
while
protein
composition
LC-MS/MS
analysis.
Results:
We
observed
clinical
isolates
exhibited
high
susceptibility
with
minimum
inhibitory
concentration
(MIC)
2.5
µg/mL
induced
rapid
hyperpolarization
caused
cytoplasmic
leakage
without
increasing
propidium
iodide
uptake.
This
accompanied
reduced
loss
survivability.
Proteomic
analysis
revealed
decreased
some
ribosomal-associated
proteins.
antioxidant
reducing
ROS
levels
dose-dependent
manner.
effect
neutralized
free
radical
scavenger
α-tocopherol,
suggesting
involvement
radicals
executing
effect.
Importantly,
not
only
prevented
biofilm
formation
biomass
preformed,
mature
biofilms.
Real-time
PCR
for
6
h
showed
increase
biofilm-associated
genes,
mainly
due
did
alter
adhere
HeLa
cervical
carcinoma
cells
CBD-treated
still
phagocytosed
RAW264.7
macrophages.
Conclusions:
Our
study
shows
exhibits
thus
potential
drug
treatment
vaginosis
bacterium.
Biomedicines,
Год журнала:
2022,
Номер
10(3), С. 631 - 631
Опубликована: Март 9, 2022
Antibiotic
resistance
has
become
an
increasing
challenge
in
the
treatment
of
various
infectious
diseases,
especially
those
associated
with
biofilm
formation
on
biotic
and
abiotic
materials.
There
is
urgent
need
for
new
protocols
that
can
also
target
biofilm-embedded
bacteria.
Many
secondary
metabolites
plants
possess
anti-bacterial
activities,
phytocannabinoids
Cannabis
sativa
L.
varieties
have
reached
a
renaissance
attracted
much
attention
their
anti-microbial
anti-biofilm
activities
at
concentrations
below
cytotoxic
threshold
normal
mammalian
cells.
Accordingly,
many
synthetic
cannabinoids
been
designed
intention
to
increase
specificity
selectivity
compounds.
The
structurally
unrelated
endocannabinoids
found
activities.
Recent
data
suggest
mutual
communication
between
endocannabinoid
system
gut
microbiota.
present
review
focuses
integrated
some
selected
issues
physiological
pharmacological
Antioxidants,
Год журнала:
2023,
Номер
12(7), С. 1390 - 1390
Опубликована: Июль 6, 2023
Cannabis
leaves
contain
a
diverse
range
of
antioxidants,
including
cannabinoids,
flavonoids,
and
phenolic
compounds,
which
offer
significant
health
benefits.
Utilising
cannabis
as
source
antioxidants
presents
cost-effective
approach
because
they
are
typically
discarded
during
the
cultivation
plants
for
their
seeds
or
fibres.
Therefore,
this
presented
study
aimed
to
assess
antioxidant
activity
selected
hemp
cultivars,
such
Białobrzeska,
Tygra,
Henola,
based
on
results
obtained
with
2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic
acid,
ferric
reducing
power,
cupric
capacity,
2,2-Diphenyl-1-picrylhydrazyl
assays.
The
cannabinoid
profile
was
analysed
contents
cannabidiol
(CBD),
cannabigerol
(CBG),
Δ9-tetrahydrocannabinol
(Δ9-THC),
cannabichromene
(CBC),
determined
chromatographic
following
variables
were
tested:
impact
various
extractants
(methanol,
ethanol,
isopropanol),
mixtures
(50:50,
v/v,
well
extraction
methods
(maceration
ultra-sound-assisted
extraction)
in
obtaining
extracts
characterised
by
different
profiles.
revealed
that
selection
extractant
conditions
significantly
influenced
active
compounds'
efficiency
activity.
Among
tested
conditions,
ultrasound-assisted
using
methanol
yielded
highest
profile:
CBD
=
184.51
±
5.61;
CBG
6.10
0.21;
Δ9-THC
0.51
0.01;
CBC
0.71
0.01
μg/g
potential
Białobrzeska
leaf
extracts.
Pharmaceutics,
Год журнала:
2024,
Номер
16(10), С. 1277 - 1277
Опубликована: Сен. 30, 2024
emerges
as
a
noteworthy
candidate
for
its
medicinal
potential,
particularly
in
wound
healing.
This
review
article
explores
the
efficacy
of
cannabis
oil
reducing
reactive
oxygen
species
(ROS)
during
healing
acute
and
chronic
wounds,
comparing
it
to
standard
treatments.
ROS,
produced
from
various
internal
external
sources,
play
crucial
role
development
by
causing
cell
tissue
damage.
Understanding
ROS
on
skin
wounds
is
essential,
they
act
both
signaling
molecules
contributors
oxidative
Cannabis
oil,
recognized
antioxidant
properties,
may
help
mitigate
damage
scavenging
upregulating
antioxidative
mechanisms,
potentially
enhancing
emphasizes
ongoing
research
future
potential
dermatological
treatments,
highlighted
through
clinical
studies
patent
updates.
Despite
promising
benefits,
optimizing
formulations
therapeutic
applications
remains
challenge,
underscoring
need
further
realize
capabilities
wounds.